pharma · Allergies · Early Parkinson Disease
Advanced Accelerator Applications
Advanced Accelerator Applications is a pharma organization headquartered in RUEIL-MALMAISON, FR. Primary therapeutic focus areas include Allergies, Early Parkinson Disease, Breast Cancer, Recurrent or Metastatic Breast C
Company details
- Status
- Public
- HQ
- 20 rue Diesel, Saint Genis Pouilly, 01630, FR, RUEIL-MALMAISON
- Employees
- 590
- Programs
- 12
- Drugs
- 25
- Patents
- 25
ODYSSEY
Phase 1 · other · Patients with Relapsed/Refractory Acute Myeloid Leukemia or High/Very-high Risk Myelodysplastic Syndromes, Ineligible for Intensiveor New Generation Targeted Therapy
ODYSSEY for Patients with Relapsed/Refractory Acute Myeloid Leukemia or High/Very-high Risk Myelodysplastic Syndromes, Ineligible for Intensiveor New Generation Targeted Therapy is a Phase 1 program (other) at Advanced Accelerator Applications with 1 ClinicalTrials.gov record(s).
Internal code ODYSSEY
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Advanced Accelerator Applications
- Phase
- Phase 1
- Modality
- other
- Indication
- Patients with Relapsed/Refractory Acute Myeloid Leukemia or High/Very-high Risk Myelodysplastic Syndromes, Ineligible for Intensiveor New Generation Targeted Therapy
- Status
- active
- Trials
- 1